| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26 |
| filingDate |
1996-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9c9523fa949a039a4ea369204063455 |
| publicationDate |
1998-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5837233-A |
| titleOfInvention |
Method for treating tumors |
| abstract |
A method is provided for treatment of a mammalian patient having a tumor by administering to the patient allogenic donor lymphocytes that have been co-cultured in the presence of the patient-derived lymphocytes under conditions sufficient to alloactivate the donor lymphocytes. It is preferred that the donor lymphocytes be introduced intralesionally. This method is preferred for treatment of glioblastoma in humans. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004082065-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008220025-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001006631-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7628996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021063384-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6203787-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006009393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7361332-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7175839-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003228300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0194551-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7871606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016206718-A1 |
| priorityDate |
1995-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |